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Abstract 
A 46-year-old woman presented for a second
opinion regarding a 3-4 cm mass of the uterine
cervix. A prior biopsy had been interpreted as a
malignant melanoma of the cervix, resulting in
a radical hysterectomy with bilateral salpingo-
oophorectomy.  This  was  to  be  followed  by
external  beam  irradiation  and  immunother  -
apy; however, given the rarity of this diagnosis,
the  patient  sought  a  second  opinion  at  our
institution. Further review of the pathological
material  from  the  hysterectomy  revealed  a
morphologically  benign  perivascular  epithe-
lioid  cell  neoplasm  rather  than  a  malignant
melanoma.  Close  monitoring  of  the  patient
was recommended; she is currently disease-
free  more  than  three  years  after  her  initial
presentation.
Introduction
Perivascular  epithelioid  cell  neoplasms
(PEComas) comprise a group of unusual vis-
ceral,  soft  tissue,  bone,  and  skin  tumors
defined  by  both  their  unique  morphological
features  and  their  characteristic  “myomel  -
anocytic”  immunophenotype.  These  tumors
co-express markers of melanocytic differenti  -
ation, such as gp100 protein (recognized by
mAb HMB45) and markers of myogenous dif-
ferentiation, such as smooth muscle actin iso-
forms.
1 Angiomyolipoma of the kidney repre-
sents  the  most  common  and  “prototypical”
PEComa, with much rarer tumors in different
anatomical  locations  having  been  described
under  such  names  as  lymphangioleiomyo  -
matosis,  clear  cell  “sugar”  tumor,  clear  cell
myomelanocytic  tumor,  and  abdominopelvic
sarcoma  of  perivascular  epithelioid  cells,
among  others.  The  differential  diagnosis  of
PEComas  is  broad  and  may  include  both
benign tumors, such as leiomyoma or lipoma,
as well as malignancies, including malignant
melanoma,  clear  cell  carcinoma,  leiomyosar  -
coma, and liposarcoma. Here we present a case
of PEComa of the uterine cervix that was ini-
tially  diagnosed  and  treated  as  a  malignant
melanoma. The differential diagnosis of this
very rare neoplasm and its classification and
treatment are reviewed.
Case Report
A  46-year-old  gravid-4,  para-1  female  pre-
sented to an outside provider in early 2007 for
evaluation  of  intermittent  vaginal  bleeding,
lasting for at least one year. The patient’s med-
ical history was significant for miscarriages,
endometriosis,  borderline  hypertension,  a
grade  1/6  intermittent  heart  murmur,  and
malaria  contracted  while  working  in  the
Philippines in her twenties. Her family history
was  significant  for  a  brother  with  multiple
myeloma and a sister with leiomyosarcoma. 
On examination by the outside provider, the
patient  was  found  to  have  a  friable  3-4  cm
mass arising from the uterine cervix. A biopsy
of this mass was performed and diagnosed as
malignant melanoma. Preoperative computer
tomography  (CT)  and  positron  emission
tomography (PET)-CT fusion scans were nega-
tive for regional or distant metastatic disease.
A  hysterectomy  with  bilateral  salpingo-
oophorectomy and regional lymph node dissec-
tion was performed.
The  pathological  specimen  from  the  hys-
terectomy revealed a 2.5ﾥ2.0ﾥ0.9 cm cervical
mass, which was considered by the patholo-
gists  at  the  outside  institution  to  represent
malignant  melanoma.  Thirty-three  lymph
nodes  were  negative  for  metastatic  disease.
On the basis of these findings it was recom-
mended that the patient receive immunother-
apy and external beam radiotherapy, possibly
with additional brachytherapy. Following these
recommendations,  the  patient  presented  to
our institution for a second opinion regarding
treatment options. On further review, the hys-
terectomy  specimen  was  felt  to  represent  a
PEComa, rather than a malignant melanoma.
This was based on its nested growth pattern,
clear to lightly acidophilic cytoplasm, relatively
low-grade  cytological  features,  absence  of
mitotic activity or necrosis (Figures 1 and 2),
and myomelanocytic immunophenotype, with
expression  of  Melan  A,  gp100  protein,  and
smooth  muscle  actins,  but  not  S100  protein
(Figures 3-5). The tumor was considered to be
morphologically benign, according to the cri  -
teria  advanced  by  the  most  widely  accepted
classification scheme for PEComas.
1 We rec-
ommended that the patient receive no addi-
tional adjuvant therapy. The patient agreed to
close observation and follow-up alone, and is
currently  without  evidence  of  disease,  42
months after the initial diagnosis. 
Discussion 
The PEComas comprise a family of related
neoplasms defined both by morphology (char-
acteristic clear to lightly eosinophilic, epithe-
lioid to slightly spindle-shaped cells arranged
in a perivascular distribution) and by immuno-
histochemistry (co-expression of melanocytic
and myoid antigens). PEComas are rare with
the  most  common  member  of  this  family,
angiomyolipoma of the kidney, having an esti-
mated prevalence of only 0.13% of the popula-
tion.
2 PEComas have been reported in a wide
variety of visceral, intra-abdominal, soft tissue,
and bone locations, and occur with some fre-
quency  in  the  gynecological  tract,  including
the uterine cervix and corpus.
3-7 PEComas of all
types most often occur in middle-aged women
(median  age,  38  years),  being  seven  times
more common in women overall and four times
more common even when gynecological sites
of origin are excluded.
1 PEComas of all types
have been associated with the tuberous scler  -
osis  complex  (TSC)  and  with  inactivating
mutations in the TSC-associated genes TSC1
or  TSC2,  although  this  association  is  much
stronger for angiomyolipoma and lymphangio  -
leiomyomatosis than it is for gynecological and
soft tissue PEComas.
8
The diagnosis of PEComa may be very chal-
lenging,  owing  to  its  rarity  and  its
morphologic  al and immunophenotypical over-
lap with other tumors, both benign and malig-
nant.  As  emphasized  by  our  case,  PEComas
may  closely  simulate  malignant  melanomas,
particularly in the setting of limited biopsies.
Important  clues  to  the  correct  diagnosis  of
PEComa include lower nuclear grade as com-
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pared with melanomas (without the prominent
macronucleoli  characteristic  of  melanomas),
nested  growth  with  a  prominent  associated
capillary  vasculature,  and  clear  to  lightly
eosinophilic  cytoplasm.  Ultimately,  however,
immunohistochemistry is critical in the dis-
tinction  between  PEComa  and  melanoma.
Although both tumor types express melanocyt-
ic markers, such as gp100 protein, Melan A,
tyrosinase, and microphthalmia transcription
factor, PEComas are typically negative for S100
protein,  expressed  in  98%  or  more  of
melanomas, and are positive for smooth mus-
cle  actin  isoforms  not  expressed  in
melanomas.
1,9,10
The  behavior  of  PEComas  remains  to  be
fully  elucidated,  owing  to  their  rarity.
However,  a  histopathological  classification
scheme has been elaborated by Folpe and col-
leagues,
11 stratifying PEComas into “benign”,
“of  uncertain  malignant  potential”,  and
“malignant”. The present case was considered
to  be  morphologically  benign,  based  on  its
small  size  (<5  cm),  intermediate  nuclear
grade,  intermediate  cellularity,  low  mitotic
rate  (≤1/50  MF/HPF),  and  absent  necrosis.
Follow-up  to  date  on  PEComas  classified  as
morphologically benign has shown them to be
clinically benign as well. 
In the unlikely event of a recurrence of this
patient’s  cancer,  treatment  options  would
include surgical resection, if feasible. The role
of  radiation  therapy  is  presently  unknown.
Standard chemotherapy for sarcomas was not
effective  in  a  recent  case  report.
12 Another
report suggests that PEComas may respond to
inhibition  of  the  mTOR  signaling  pathway
using  sirolimus  or  temsirolimus.
13 Owing  to
the  rarity  of  these  tumors  and  their  mixed 
histological features, effective treatments are
still being developed for malignant PEComas. 
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Case Report
Figure  3.  Immunohistochemical  staining
demonstrates that the PEComa is positive
for Melan A.
Figure  4.  Immunohistochemical  staining
of the PEComa is positive for smooth mus-
cle actin.
Figure  5.  Immunohistochemistry  demon-
strates  that  this  PEComa  is  negative  for
S100, a feature which can be used to distin-
guish between a PEComa and a melanoma. 
Figure 1. Hematoxylin-and-eosin stain of
PEComa  tissue  slice  at  100X  magnifica-
tion. Note the nested growth pattern, clear
to lightly acidophilic cytoplasm, relatively
low-grade cytological features and absence
of mitotic activity or necrosis, which are
consistent with a benign PEComa. 
Figure 2. Hematoxylin-and-eosin stain of
PEComa at 200X magnification.